Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $818.7000 (3.62%) ($818.7000 - $818.7000) on Thu. Nov. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.3% (three month average) | RSI | 41 | Latest Price | $818.7000(3.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(65%) IBB(56%) DIA(51%) SDY(51%) SPLV(51%) | Factors Impacting REGN price | REGN will decline at least -0.65% in a week (0% probabilities). VXX(-49%) VIXM(-38%) TBT(-25%) UNG(-15%) USO(-13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.65% (StdDev 1.3%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $790.48(-3.45%) | 5 Day Moving Average | $788.27(3.86%) | 10 Day Moving Average | $793.56(3.17%) | 20 Day Moving Average | $812.17(0.8%) | To recent high | -3.2% | To recent low | 11.8% | Market Cap | $86.806b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |